Novo Nordisk A/S
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public
- Established
- 1923-01-01
- Employees
- 63.3K
- Market Cap
- $602.2B
- Website
- http://www.novonordisk.com
Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2
- First Posted Date
- 2011-12-02
- Last Posted Date
- 2018-11-01
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 1344
- Registration Number
- NCT01484262
- Locations
- 🇩🇪
Novo Nordisk Investigational Site, Mainz, Germany
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Phase 3
Completed
- Conditions
- Congenital Bleeding DisorderHaemophilia A
- Interventions
- First Posted Date
- 2011-11-28
- Last Posted Date
- 2020-11-23
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 186
- Registration Number
- NCT01480180
- Locations
- 🇬🇧
Novo Nordisk Investigational Site, Sheffield, United Kingdom
Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women
Phase 1
Completed
- Conditions
- MenopauseHealthy
- Interventions
- First Posted Date
- 2011-11-22
- Last Posted Date
- 2016-01-15
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 24
- Registration Number
- NCT01477632
Observational Registry of the Treatment of Glanzmann's Thrombasthenia
Completed
- Conditions
- Congenital Bleeding DisorderGlanzmann's Disease
- Interventions
- Drug: activated recombinant human factor VII
- First Posted Date
- 2011-11-22
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 218
- Registration Number
- NCT01476423
- Locations
- 🇺🇸
Novo Nordisk Clinical Trial Call Center, Princeton, New Jersey, United States
Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects
Phase 1
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 2Healthy
- Interventions
- Drug: placebo
- First Posted Date
- 2011-11-17
- Last Posted Date
- 2017-03-23
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 31
- Registration Number
- NCT01473953
- Locations
- 🇺🇸
Novo Nordisk Investigational Site, Evansville, Indiana, United States
A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 1Diabetes
- Interventions
- First Posted Date
- 2011-11-10
- Last Posted Date
- 2015-02-23
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 40
- Registration Number
- NCT01469143
Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes
Phase 4
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 1
- Interventions
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 26
- Registration Number
- NCT01467141
- Locations
- 🇩🇪
Novo Nordisk Investigational Site, Osnabrück, Germany
A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2013-11-27
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 1
- Registration Number
- NCT01467414
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes
Phase 3
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
- Interventions
- Drug: biphasic human insulin
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2017-01-04
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 303
- Registration Number
- NCT01467323
- Locations
- 🇬🇧
Novo Nordisk Investigational Site, Whiston, United Kingdom
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.
Phase 3
Completed
- Conditions
- Haemophilia BCongenital Bleeding Disorder
- Interventions
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 25
- Registration Number
- NCT01467427
- Locations
- 🇬🇧
Centre for Haemophilia, Haemostasis and Thrombosis, Basingstoke, United Kingdom
🇬🇧Leicester Royal Infirmary, Leicester, United Kingdom
🇬🇧John Radcliffe Hospital, Oxford, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath